Workflow
存款类产品
icon
Search documents
苏利股份: 苏利股份关于开立募集资金现金管理专用结算账户的公告
Zheng Quan Zhi Xing· 2025-06-13 10:07
证券代码:603585 证券简称:苏利股份 公告编号:2025-054 转债代码:113640 转债简称:苏利转债 江苏苏利精细化工股份有限公司 关于开立募集资金现金管理专用结算账户的公告 近日,公司子公司苏利(宁夏)新材料科技有限公司在兴业银行股份有限 公司江阴支行开立了募集资金现金管理专用结算账户,账户信息如下: 开户银行:兴业银行股份有限公司江阴支行 账户名称:苏利(宁夏)新材料科技有限公司 账号:408480100100460999 根据《上市公司监管指引第 2 号—上市公司募集资金管理和使用的监管要 求》、 《上海证券交易所上市公司自律监管指引第 1 号—规范运作》等相关规定, 募集资金现金管理专用结算账户将专用于闲置募集资金现金管理投资产品的结 算,不会存放非募集资金或用作其他用途。公司将在现金管理产品到期且无下 一步使用或购买计划时及时注销该账户。 二、风险控制措施 《上市公司监管指引 本公司董事会及全体董事保证本公告内容不存在任何虚假记载、误导性陈 述或者重大遗漏,并对其内容的真实性、准确性和完整性承担个别及连带责任。 江苏苏利精细化工股份有限公司(以下简称"公司")于 2025 年 4 月 ...
艾布鲁: 第三届监事会第十四次会议决议公告
Zheng Quan Zhi Xing· 2025-05-30 08:10
证券代码:301259 证券简称:艾布鲁 公告编号:2025-028 湖南艾布鲁环保科技股份有限公司 本公司及监事会全体成员保证信息披露内容的真实、准确和完整,没有虚 假记载、误导性陈述或重大遗漏。 一、监事会会议召开情况 湖南艾布鲁环保科技股份有限公司(以下简称"公司")第三届监事会第十 四次会议(以下简称"本次会议")通知于 2025 年 5 月 27 日以通讯方式送达公 司全体监事,会议于 2025 年 5 月 30 日上午 11:00 以现场结合通讯的方式召开, 其中监事曾睿以通讯方式参加。本次会议由监事会主席曾睿先生召集并主持,本 次会议应到会监事 3 人,实际到会监事 3 人。 本次会议的召集、召开符合《中华人民共和国公司法》和《公司章程》的有 关规定。 二、监事会会议审议情况 上述额度自公司董事会审议通过之日起 12 个月内可循环滚动使用,并授权 公司董事长或董事长授权人士在有效期内和额度范围内签署相关合同文件,具体 事项由公司财务部门组织实施。 具体内容详见同日刊登于中国证监会指定信息披露媒体巨潮资讯网 (http://www.cninfo.com.cn)上的《关于使用闲置自有资金及部分暂时闲 ...
泽璟制药: 中国国际金融股份有限公司关于苏州泽璟生物制药股份有限公司使用部分暂时闲置募集资金进行现金管理事项的核查意见
Zheng Quan Zhi Xing· 2025-05-16 12:24
Core Viewpoint - The company intends to utilize part of its temporarily idle raised funds for cash management to enhance fund efficiency and generate additional returns while ensuring the safety of the raised funds and the implementation of investment projects [1][2][6]. Fundraising Basic Situation - The company was approved to publicly issue 60,000,000 A shares at a price of RMB 33.76 per share, raising a total of RMB 2,025,600,000, with a net amount of RMB 1,908,220,754.68 after deducting related fees [1]. - Additionally, the company was authorized to issue shares to specific targets, raising RMB 1,199,999,955.00, with a net amount of RMB 1,181,933,181.59 after deducting issuance costs [2]. Cash Management Plan - The company plans to use up to RMB 4 billion from the idle funds raised from the initial public offering and up to RMB 8.5 billion from the funds raised from the specific target issuance for cash management [3][4]. - The investment will focus on low-risk, high-liquidity financial products, including but not limited to structured deposits and time deposits, with a maximum investment period of one year [3][4]. Decision Validity and Disclosure - The decision to use idle funds for cash management is valid for 12 months from June 15, 2025, and the company will comply with information disclosure obligations as per regulatory requirements [4][5]. - The income generated from cash management will be prioritized for supplementing investment project funding and daily operational liquidity [4]. Impact on Daily Operations - The cash management plan will not affect the normal operation of the company's investment projects or its main business activities, while also potentially enhancing overall performance and shareholder returns [4][5]. Risk Control Measures - The company has established a risk control framework for cash management, including selecting quality banks and monitoring investment performance to mitigate potential risks [5][6]. - The company will ensure compliance with relevant regulations and maintain a separation of decision-making, execution, and supervision functions in cash management activities [5][6]. Review Procedures - The board of directors approved the cash management plan, which does not require shareholder meeting approval, ensuring adherence to necessary procedures [6][7].
泽璟制药: 泽璟制药关于使用部分暂时闲置募集资金进行现金管理的公告
Zheng Quan Zhi Xing· 2025-05-16 12:15
Core Viewpoint - The company plans to utilize part of its temporarily idle raised funds for cash management, aiming to enhance fund efficiency and generate additional returns while ensuring the safety and proper use of the funds [2][4][8] Fundraising Overview - The company was approved to publicly issue 60 million A-shares at a price of RMB 33.76 per share, raising a total of RMB 2,025,000,000, with a net amount of RMB 1,908,220,754.68 after deducting issuance costs [3] - In April 2023, the company issued 24,489,795 A-shares at RMB 49.00 per share, raising RMB 1,199,999,955, with a net amount of RMB 1,181,933,181.59 after costs [3] Cash Management Plan - The company intends to use up to RMB 4 billion from the idle funds raised from the initial public offering and up to RMB 8.5 billion from the funds raised through a private placement for cash management [2][5] - The cash management will involve purchasing low-risk, liquid principal-protected financial products or deposit products, ensuring that these funds are not used for pledging or securities investments [4][5] Investment Objectives - The primary goal is to improve the efficiency of fund usage and generate additional income without affecting the implementation of investment projects or the safety of the raised funds [4][6] Decision Validity and Management - The decision is valid for 12 months starting from June 15, 2025, and funds can be rolled over within the specified limits [5] - The company’s financial department is responsible for organizing and implementing the cash management activities [5][6] Impact on Daily Operations - The cash management plan will not affect the normal operation of the company’s main business or the regular turnover of funds [6] - The investment returns will be prioritized for supplementing project funding shortfalls and supporting daily operational liquidity [5][6] Regulatory Compliance - The company will adhere to relevant regulations and timely disclose information as required by the China Securities Regulatory Commission and the Shanghai Stock Exchange [5][8] - The sponsor institution has confirmed that the cash management plan complies with regulatory requirements and does not alter the intended use of the raised funds [8]